Stratagene Shares Plummet 9.3 Percent After Jury Sides With Third Wave in IP Suit | GenomeWeb

NEW YORK, Sept. 1 (GenomeWeb News) - Shares in Stratagene plummeted 9.3 percent and Third Wave Technologies' stock jumped 7.4 percent after Third Wave said it won its patent-infringement suit against Stratagene today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.